The Cooper Companies, Inc. (NASDAQ:COO) Shares Bought by Buckhead Capital Management LLC

Buckhead Capital Management LLC grew its holdings in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 9.5% in the first quarter, according to its most recent disclosure with the SEC. The fund owned 52,711 shares of the medical device company's stock after buying an additional 4,591 shares during the period. Cooper Companies accounts for approximately 1.4% of Buckhead Capital Management LLC's portfolio, making the stock its 29th largest position. Buckhead Capital Management LLC's holdings in Cooper Companies were worth $4,446,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. City Holding Co. acquired a new stake in shares of Cooper Companies during the 1st quarter valued at approximately $34,000. New Age Alpha Advisors LLC acquired a new stake in shares of Cooper Companies during the 4th quarter valued at approximately $38,000. Covestor Ltd lifted its position in shares of Cooper Companies by 35.5% during the 4th quarter. Covestor Ltd now owns 458 shares of the medical device company's stock valued at $42,000 after acquiring an additional 120 shares during the period. Larson Financial Group LLC lifted its position in shares of Cooper Companies by 1,071.0% during the 1st quarter. Larson Financial Group LLC now owns 726 shares of the medical device company's stock valued at $61,000 after acquiring an additional 664 shares during the period. Finally, HM Payson & Co. lifted its position in shares of Cooper Companies by 147.4% during the 1st quarter. HM Payson & Co. now owns 893 shares of the medical device company's stock valued at $75,000 after acquiring an additional 532 shares during the period. 24.39% of the stock is owned by hedge funds and other institutional investors.

Cooper Companies Stock Down 0.9%

COO stock traded down $0.63 during trading on Friday, reaching $72.63. The stock had a trading volume of 1,870,502 shares, compared to its average volume of 1,769,990. The Cooper Companies, Inc. has a 1-year low of $65.00 and a 1-year high of $112.38. The company has a current ratio of 2.10, a quick ratio of 1.23 and a debt-to-equity ratio of 0.30. The company has a market capitalization of $14.52 billion, a P/E ratio of 35.26, a PEG ratio of 1.77 and a beta of 0.99. The firm has a fifty day moving average price of $74.03 and a 200 day moving average price of $81.98.

Cooper Companies (NASDAQ:COO - Get Free Report) last released its earnings results on Thursday, May 29th. The medical device company reported $0.96 earnings per share for the quarter, topping the consensus estimate of $0.93 by $0.03. The company had revenue of $1 billion during the quarter, compared to the consensus estimate of $995.12 million. Cooper Companies had a net margin of 10.39% and a return on equity of 9.60%. The company's revenue was up 6.3% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.85 EPS. On average, equities analysts anticipate that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Analyst Ratings Changes

A number of brokerages have recently weighed in on COO. JPMorgan Chase & Co. reissued a "neutral" rating and set a $76.00 price objective (down from $110.00) on shares of Cooper Companies in a research note on Friday, May 30th. Wall Street Zen cut shares of Cooper Companies from a "buy" rating to a "hold" rating in a research note on Saturday, July 12th. Loop Capital set a $100.00 price objective on shares of Cooper Companies in a research note on Tuesday, June 17th. Mizuho dropped their price objective on shares of Cooper Companies from $105.00 to $90.00 and set an "outperform" rating for the company in a research note on Wednesday. Finally, Robert W. Baird dropped their price objective on shares of Cooper Companies from $107.00 to $97.00 and set an "outperform" rating for the company in a research note on Friday, May 30th. Four investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $97.20.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.